TABLE 2.
Incidence rate of incident NAFLD.
| eGFR | Participants (n) | NAFLD events (n) | Incidence rate (95% CI) (%) | Per 1,000 person-year |
| Total | 15,555 | 2,077 | 13.35 (12.82–13.89) | 47.49 |
| TG < 1.7 mmol/L | ||||
| Q1 (<82.88) | 2,910 | 424 | 14.67 (13.39–15.96) | 55.09 |
| Q2 (82.88–99.70) | 3,116 | 341 | 10.94 (9.85–12.04) | 40.18 |
| Q3 (99.70–116.56) | 3,302 | 229 | 6.94 (6.07–7.80) | 24.12 |
| Q4 (≥116.56) | 3,496 | 157 | 4.49 (3.80–5.18) | 14.72 |
| P for trend | <0.0001 | |||
| TG ≥ 1.7 mmol/L | ||||
| Q1 (<82.88) | 978 | 371 | 37.93 (34.89–40.98) | 151.89 |
| Q2 (82.88–99.70) | 769 | 269 | 34.98 (31.60–38.36) | 130.56 |
| Q3 (99.70–116.56) | 587 | 187 | 31.86 (28.08–35.64) | 115.79 |
| Q4 (≥116.56) | 397 | 96 | 24.18 (19.95–28.41) | 75.44 |
| P for trend | <0.0001 | |||
eGFR, estimated glomerular filtration rate (mL/min⋅1.73 m2); NAFLD, non–alcoholic fatty liver disease.